- Shengjiang Tan
(Cambridge Biomedical Campus Keith Peters Building, Hills Rd
Cambridge Biomedical Campus
Cambridge Biomedical Campus)
- Laëtitia Kermasson
(Université de Paris, Imagine Institute, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le Cancer, INSERM UMR 1163)
- Christine Hilcenko
(Cambridge Biomedical Campus Keith Peters Building, Hills Rd
Cambridge Biomedical Campus
Cambridge Biomedical Campus)
- Vasileios Kargas
(Cambridge Biomedical Campus Keith Peters Building, Hills Rd
Cambridge Biomedical Campus
Cambridge Biomedical Campus)
- David Traynor
(Cambridge Biomedical Campus Keith Peters Building, Hills Rd
Cambridge Biomedical Campus
Cambridge Biomedical Campus)
- Ahmed Z. Boukerrou
(Cambridge Biomedical Campus Keith Peters Building, Hills Rd
Cambridge Biomedical Campus
Cambridge Biomedical Campus)
- Norberto Escudero-Urquijo
(Cambridge Biomedical Campus Keith Peters Building, Hills Rd
Cambridge Biomedical Campus
Cambridge Biomedical Campus)
- Alexandre Faille
(Cambridge Biomedical Campus Keith Peters Building, Hills Rd
Cambridge Biomedical Campus
Cambridge Biomedical Campus)
- Alexis Bertrand
(Université de Paris, Imagine Institute, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le Cancer, INSERM UMR 1163)
- Maxim Rossmann
(Cambridge Biomedical Campus Keith Peters Building, Hills Rd
Cambridge Biomedical Campus
Cambridge Biomedical Campus)
- Beatriz Goyenechea
(Cambridge Biomedical Campus
PolyProx Therapeutics, Babraham Research Campus)
- Li Jin
(Cambridge Biomedical Campus
MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus)
- Jonathan Moreil
(Université de Paris, Imagine Institute, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le Cancer, INSERM UMR 1163)
- Olivier Alibeu
(INSERM Unité Mixte de Recherche 1163, Structure Fédérative de Recherche Necker INSERM US24/CNRS UMS3633, Genomic Core Facility, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute)
- Blandine Beaupain
(Assistance Publique-Hôpitaux de Paris, Trousseau Hospital)
- Christine Bôle-Feysot
(INSERM Unité Mixte de Recherche 1163, Structure Fédérative de Recherche Necker INSERM US24/CNRS UMS3633, Genomic Core Facility, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute)
- Stefano Fumagalli
(Institut Necker Enfants Malades
INSERM, U1151, Université Paris Descartes Sorbonne Cité)
- Sophie Kaltenbach
(Université Paris Descartes, Faculté de Médecine Sorbonne Paris Cité
Service de cytogénétique, Hôpital Necker, Assistance Publique-Hôpitaux de Paris)
- Jean-Alain Martignoles
(Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, AP-HP, Hôpital Saint-Antoine, Hématologie Biologique)
- Cécile Masson
(INSERM Unité Mixte de Recherche 1163, Bioinformatics Platform, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute)
- Patrick Nitschké
(INSERM Unité Mixte de Recherche 1163, Bioinformatics Platform, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute)
- Mélanie Parisot
(INSERM Unité Mixte de Recherche 1163, Structure Fédérative de Recherche Necker INSERM US24/CNRS UMS3633, Genomic Core Facility, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute)
- Aurore Pouliet
(INSERM Unité Mixte de Recherche 1163, Structure Fédérative de Recherche Necker INSERM US24/CNRS UMS3633, Genomic Core Facility, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute)
- Isabelle Radford-Weiss
(Université Paris Descartes, Faculté de Médecine Sorbonne Paris Cité
Service de cytogénétique, Hôpital Necker, Assistance Publique-Hôpitaux de Paris)
- Frédéric Tores
(INSERM Unité Mixte de Recherche 1163, Bioinformatics Platform, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute)
- Jean-Pierre Villartay
(Université de Paris, Imagine Institute, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le Cancer, INSERM UMR 1163)
- Mohammed Zarhrate
(INSERM Unité Mixte de Recherche 1163, Structure Fédérative de Recherche Necker INSERM US24/CNRS UMS3633, Genomic Core Facility, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute)
- Ai Ling Koh
(KK Women’s and Children’s Hospital
SingHealth Duke-NUS Genomic Medicine Centre)
- Kong Boo Phua
(KK Women’s and Children’s Hospital
SingHealth Duke-NUS Genomic Medicine Centre)
- Bruno Reversade
(Genome Institute of Singapore, A*STAR, Biopolis)
- Peter J. Bond
(Bioinformatics Institute (A*STAR)
National University of Singapore)
- Christine Bellanné-Chantelot
(Sorbonne University)
- Isabelle Callebaut
(Sorbonne Université, Muséum National d’Histoire Naturelle, UMR CNRS 7590, Institut de Minéralogie, de Physique des Matériaux et de Cosmochimie, IMPMC)
- François Delhommeau
(Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, AP-HP, Hôpital Saint-Antoine, Hématologie Biologique)
- Jean Donadieu
(Registre des neutropénies-Centre de référence des neutropénies chroniques)
- Alan J. Warren
(Cambridge Biomedical Campus Keith Peters Building, Hills Rd
Cambridge Biomedical Campus
Cambridge Biomedical Campus)
- Patrick Revy
(Université de Paris, Imagine Institute, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le Cancer, INSERM UMR 1163)